DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: Fail-safe protection against carcinogenesis

Mutation Research - Reviews in Mutation Research

Volumn 511, Issue 2, 2002, Pages 145-178

  Bernstein, Carol ^a   Bernstein, Harris ^a   Payne, Claire M ^a   Garewal, Harinder ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Carcinogenesis; DNA repair

Indexed keywords

ABELSON KINASE; ATM PROTEIN; ATR PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CASPASE 3; DNA; ENDONUCLEASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MISMATCH REPAIR PROTEIN PMS2; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PROTEIN; PROTEIN BER; PROTEIN BLM; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN NER; PROTEIN NHEJ; PROTEIN P33; PROTEIN P53; PROTEIN TIP60; PROTEIN XPB; RAD51 PROTEIN; REDOX EFFECTOR FACTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; WERNER SYNDROME PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

APOPTOSIS; ARTICLE; BLOOM SYNDROME; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EXCISION REPAIR; GENE INSERTION; GENE MUTATION; GENETIC DISORDER; HOMOLOGOUS RECOMBINATION; HUMAN; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SAFETY; WERNER SYNDROME;

ALOCASIA MACRORRHIZOS; ZIZIPHUS MAURITIANA;

EID: 0036270993     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00009-1     Document Type: Review

References (292)

1. Role of apoptosis in biology and pathology: Resistance to apoptosis in colon carcinogenesis
2. Reduced bile acid-induced apoptosis in normal colorectal mucosa: A potential biological marker for cancer risk
3. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies
4. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus
5. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study
6. Mutations in apoptosis genes: A pathogenetic factor for human disease
7. P53, the cellular gatekeeper for growth and division
8. Inhibition of Bax channel-forming activity by Bcl-2
9. L promotes susceptibility to mutagenesis
10. Molecular failure of apoptosis: Inappropriate cell survival and mutagenesis
11. Suppression of apoptosis by Bcl-2 to enhance benzene metabolites-induced oxidative DNA damage and mutagenesis: A possible mechanism of carcinogenesis
12. Genetic instabilities in human cancers
13. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance
14. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways
15. The shape of cell death
16. Apoptosis
17. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury
18. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
19. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
20. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
21. Poly(ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: Mechanism of stimulation of unscheduled DNA synthesis
22. Alterations in deoxynucleoside triphosphate metabolism in DNA damaged cells: Identification and consequences of poly(ADP-ribose) polymerase dependent and independent processes
23. Relating biochemistry to biology: How the recombinational repair function of RecA protein is manifested in its molecular properties
24. + depletion
25. RecA protein: Structure, function, and role in recombinational DNA repair
26. ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes
27. P53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide
28. M, Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex
29. The RAD51 family member, RAD51L3, is a DNA-stimulated ATPase that forms a complex with XRCC2
30. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor
31. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily
32. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose)
33. Distinct MutS DNA-binding modes that are differentially modulated by ATP binding and hydrolysis
34. ATM phosphorylates histone H2AX in response to DNA double-strand breaks
35. Direct observation of three conformations of MutS protein regulated by adenine nucleotides
36. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
37. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
38. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c
39. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis
40. Energy requirement for caspase activation and neuronal cell death
41. Intracellular calcium homeostasis
42. + efflux in the activation of apoptosis
43. Review: Breaking the mitochondrial barrier
44. The apoptosome: Heart and soul of the cell death machine
45. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
46. Mitochondria as the central control point of apoptosis
47. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling
48. The mitochondrial apoptosome: A killer unleashed by the cytochrome seas
49. Programmed cell death: Alive and well in the new millennium
50. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
51. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
52. +] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release
53. + inhibit cytochrome c-dependent formation of the apoptosome
54. Cleavage of ATM during radiation-induced apoptosis: Caspase-3-like apoptotic protease as a candidate
55. Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases
56. DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis
57. Proteolytic cleavage of HsRad51 during apoptosis
58. Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage
59. Caspase-3 mediated cleavage of HsRad51 at an unconventional site
60. Specific proteolytic cleavage of poly(ADP-ribose) polymerase - An early marker of chemotherapy-induced apoptosis
61. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis
62. Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: Relationship to DNA fragmentation and cell cycle position during apoptosis
63. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines
64. Mechanisms of p53-dependent apoptosis
65. Bh3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability
66. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis
67. DNA microarray analysis of genes involved in p53 mediated apoptosis: Activation of Apaf-1
68. + precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate
69. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells
70. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: Implications for apoptosis
71. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
72. Field defects in progression to adenocarcinoma of the colon and esophagus
73. Human DNA repair genes
74. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
75. BRCA1 and BRCA2 in DNA repair and genome stability
76. BRCA1, BRCA2 and RAD51 operate in a common DNA damage response pathway
77. BRCA1 upregulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum (II)
78. BRCA1 controls homology-directed DNA repair
79. Homology-directed DNA repair, mitomycin-C resistance, and chromosome stability is restored with correction of a Brca1 mutation
80. BRCA1 regulates p53-dependent gene expression
81. BRCA1 activation of the GADD45 promoter
82. GADD45 induction of a G2/M cell cycle checkpoint
83. Tumor suppressor p53 is required to modulate BRCA1 expression
84. Repression of BRCA1 through a feedback loop involving p53
85. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
86. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer lines
87. Epidemiology prevention, and early detection of breast cancer
88. Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer
89. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: Preliminary study
90. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
91. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
92. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
93. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
94. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
95. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions
96. Insights into the functions of BRCA1 and BRCA2
97. The BRCA2 gene product functionally interacts with p53 and RAD51
98. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining
99. Cancer risk and the ATM gene: A continuing debate
100. Cellular radiosensitivity in ataxia-telangiectasia
101. Targeting double-strand breaks to replicating DNA identifies a subpathway of double-strand break repair that is defective in ataxia-teleangiectasia cells
102. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl
103. C-Abl: Activation and nuclear targets
104. C-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance
105. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation
106. ATM and ATR: Networking cellular responses to DNA damage
107. Breast cancer genes and DNA repair
108. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks
109. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies
110. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
111. Enhanced phosphorylation of p53 by ATM in response to DNA damage
112. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
113. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with MDM2
114. DNA damage activates p53 through a phosphorylation-acetylation cascade
115. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation
116. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
117. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
118. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
119. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
120. Chk2 activation dependence on Nbs1 after DNA damage
121. Dual roles of ATM in the cellular response to radiation and in cell growth
122. Immature thymocytes undergoing receptor rearrangements are resistant to an ATM-dependent death pathway activated in mature T cells by double-stranded DNA breaks
123. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation
124. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
125. Role for the p53 homologue p73 in E2F-1-induced apoptosis
126. ATM dependent apoptosis in the nervous system
127. ATM and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system
128. Cleavage and inactivation of ATM during apoptosis
129. Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: A novel mutation target of microsatellite instability
130. ATR disruption leads to chromosomal fragmentation and early embryonic lethality
131. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
132. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1
133. Regulation of Rad51 function by c-Abl in response to DNA damage
134. C-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance
135. Functional interaction between DNA-PK and c-Abl in response to DNA damage
136. C-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination
137. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products
138. Interaction of c-Abl and p73α and their collaboration to induce apoptosis
139. P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
140. DNA helicase deficiencies associated with cancer predisposition and premature aging disorders
141. Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51
142. Werner syndrome cells are sensitive to DNA crosslinking drugs
143. P53-mediated apoptosis is attenuated in Werner syndrome cells
144. Functional interaction of p53 and BLM DNA helicase in apoptosis
145. Physical and functional interaction between p53 and the Werner's syndrome protein
146. Werner syndrome protein contributes to induction of p53 by DNA damage
147. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
148. Human p53 binds Holliday junctions strongly and facilitates their cleavage
149. P53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction
150. P53 exhibits 3′-to-5′ exonuclease activity
151. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro
152. Activities of human recombination protein Rad51
153. Antisense inhibition of the RAD51 enhances radiosensitivity
154. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53
155. Double-strand break repair
156. Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cell
157. DNA double strand break repair in mammalian cells
158. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells
159. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
160. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53
161. Interaction of p53 and DNA-PK in response to nucleoside analogues: Potential role as a sensor complex for DNA damage
162. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell cycle arrest
163. The p53-response to DNA damage in vivo is independent of DNA-dependent protein kinase
164. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage
165. DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts
166. DNA-dependent protein kinase catalytic subunit is cleaved during UV-induced apoptosis
167. Recognition of DNA adducts by human nucleotide excision repair
168. Affinity purification of human DNA repair/transcription factor TFIIH using epitope-tagged xeroderma pigmentosum B protein
169. Genomic heterogeneity of nucleotide excision repair
170. Nucleotide excision repair in mammalian cells
171. Stopped-flow kinetic analysis of replication protein A-binding DNA
172. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair
173. Damage recognition in nucleotide excision repair of DNA
174. P53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation
175. DNA repair is activated in early stages of p53-induced apoptosis
176. Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes
177. P53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
178. The xeroderma pigmentosum group D (XPD) gene: One gene, two functions, three diseases
179. TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair
180. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway
181. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: Possible role of TFIIH in p53-mediated apoptotic cell death
182. Genetic polymorphisms in DNA repair genes and risk of lung cancer
183. Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal cell carcinoma
184. XPD/ERCC2 polymorphisms and risk of head and neck cancer: A case-control analysis
185. Transcription factor IIH: A key player in the cellular response to DNA damage
186. P53 modulation of TFIIH-associated nucleotide excision-repair activity
187. Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype
188. A 3′ → 5′ XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription
189. The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes
190. Hepatitis-B-virus-x protein inhibits p53 sequence-specific DNA-binding, transcriptional activity, and association with transcription factor ERCC3
191. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair
192. P53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes
193. Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand
194. P53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage
195. P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by ser-46-phosphorylated p53
196. ING1 mediates repair of UV-damaged DNA
197. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis
198. Going APE over ref-1
199. DNA polymerase β-mediated long patch base excision repair
200. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer
201. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo
202. Radiation-induced cell cycle arrest compromised by p21 deficiency
203. A role of cyclin G in the process of apoptosis
204. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells
205. Poly(ADP-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability
206. The stress-response proteins poly(ADP-ribose) polymerase and NF-κB protect against bile salt induced apoptosis
207. Analysis of ADP-ribose polymer sizes in intact cells
208. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage
209. 2+-dependent endonuclease in apoptosis and its inhibition by poly(ADP-ribose) polymerase
210. Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation
211. Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates
212. Effect of nicotinic acid supplementation in vivo on oxygen radical-induced genetic damage in human lymphocytes
213. + and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats
214. DNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)ation but have different requirements for p53
215. Defective induction but normal activation and function of p53 in mouse lacking poly-ADP-ribose polymerase
216. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts
217. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
218. Absence of stimulation of poly(ADP-ribose) polymerase activity in patients predisposed to colon cancer
219. Structural and functional involvement of p53 in BER in vitro and in vivo
220. A role for p53 in base excision repair
221. P53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress
222. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome)
223. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents
224. Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress
225. Mismatch repair defects in cancer
226. HMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
227. 6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent
228. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
229. 6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents
230. 6-methyl guanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in human colorectal mutagenesis
231. Post-translational modifications and activation of p53 by genotoxic stresses
232. P53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
233. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells
234. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation
235. Proteolytic cleavage of p53: A model for the activation of p53 in response to DNA damage
236. MDM2 promotes the rapid degradation of p53
237. Regulation of p53 stability by MDM2
238. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein
239. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
240. C-Abl neutralizes the inhibitory effect of Mdm2 on p53
241. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein
242. P300/MDM2 complexes participate in MDM2 mediated p53 degradation
243. P53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and/or gadd45 genes
244. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene
245. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2
246. Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene
247. Rare loss-of-function mutation of a death receptor gene in head and neck cancer
248. Investigation of the subcellular-distribution of the Bcl-2 oncoprotein-residence in the nuclear-envelope, endoplasmic-reticulum and outer mitochondrial-membranes
249. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
250. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
251. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
252. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
253. C-Myc is necessary of DNA damage-induced apoptosis in the G2 phase of the cell cycle
254. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria
255. Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner
256. P53-dependent and -independent links between DNA-damage apoptosis and mutation frequency in ES cells
257. The Li-Fraumini syndrome
258. Database of p53 gene somatic mutations in human tumors and cell-lines
259. Heterozygous germ line hCHD2 mutations in Li-Fraumini syndrome
260. Increased frequencies of gene and chromosome mutations after X-irradiation in mouse embryonal carcinoma cells transfected with the bcl-2 gene
261. Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress BCL2
262. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia
263. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables
264. Differential expression of the bcl-2 oncogene in human basal cell carcinoma
265. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
266. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
267. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
268. Endogenous mutagens and the causes of aging and cancer
269. Endogenous lesions, S phase-independent spontaneous mutations and evolutionary strategies
270. Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis
271. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids
272. Secondary bile acid induced DNA damage in HT29 cells: Are free radicals involved?
273. Dysfunctional apoptosome activation in ovarian cancer: Implications for chemoresistance
274. Transcription factor NF-κB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells
275. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
276. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase
277. Nuclear factor-κB, cancer, and apoptosis
278. BRCA1 required for transcription-coupled repair of oxidative DNA damage
279. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
280. Induction of cellular p53 activity by DNA-damaging agents and growth arrest
281. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery
282. Li-Fraumini syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance
283. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts
284. P53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
285. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas family
286. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53
287. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: Definition of a family of DNA repair enzymes
288. Nijmegen breakage syndrome
289. The DNA double-strand break repair gene hMre11 is mutated in individuals with an ataxia telangiectasia-like disorder (ATLD)
290. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
291. Polymerase η deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair
292. Transcription-coupled repair deficiency and mutations in human mismatch repair genes